First CRISPR gene-editing treatment approved in U.S.
Blood sample tube with blood for Sickle Cell Screen -Test. Sickle cell blood test, abnormal hemoglobin test.Md Babul Hosen | Istock | Getty ImagesThe U.S. Food and Drug Administration on Friday approved the country's first gene-editing treatment, Casgevy, for use in patients with sickle cell disease.The approval comes about...